Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
Característiques principals
Topics of the 7th Call:
  • Validation of translational imaging methods in drug safety assessment (TRISTAN)
  • Identification of druggable targets modulating misfolded proteins in Alzheimer’s and Parkinson’s diseases
  • Pathological neuron-glia interactions in neuropathic pain
  • Dry age-related macular degeneration: development of novel clinical endpoints for clinical trials with a regulatory and patient access intention
  • A comprehensive ‘paediatric preclinical POC platform’ to enable clinical molecule development for children with cancer

    Topics under the Big Data for Better Outcomes programme;
  • Coordination and support action (CSA) for the big data for better outcomes programme
  • Increase access and use of high quality data to improve clinical outcomes in heart failure (HF), atrial fibrillation (AF), and acute coronary syndrome (ACS) patients.

    Topic of the 8th call:
  • Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks.
    		•
    Característiques principals
    This Call is being run in a two stage submission and evaluation process.
    Short proposals for this call can only be done through the IMI SOFIA software tool:
    https://sofia.imi.europa.eu/Pages/Login.aspx?ReturnUrl=%2fPages%2fDefault.aspx
    Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    • Carol Barnwell, cbarnwell@imim.es. Ext.: 1670
    • Marta López, mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    7th Call:
    http://www.imi.europa.eu/content/imi-2-call-7-0
    8th Call:
    http://www.imi.europa.eu/content/imi-2-call-8
    Dotació
    IMI JU collaborative projects are implemented through a co-financing scheme. The IMI JU grants financial support to the eligible entities, while the other entities (including the EFPIA companies) participate in the project with their own resources.
    The EU contribution is:
    7th call:
  • Topic 1: 12.000.000 EUR
  • Topic 2: 4.685.000 EUR
  • Topic 3: 1.500.000 EUR
  • Topic 4: 8.025.000 EUR
  • Topic 5: 7.370.000 EUR
  • Topic 6: 3.550.000 EUR
  • Topic 7: 9.672.000 EUR
    8th call:
  • Topic 1: 70.000.000 EUR
    • AVÍS IMPORTANT
    IMI will hold webinars on each topic of the 7th and 8th Calls for proposals, as well as one webinar on the IMI2 rules and procedures.
    The webinars represent an excellent opportunity to learn more about the Call topics, interact directly with the topic coordinators, and get in touch with potential project partners.
    Webinar schedule and registration:
    http://www.imi.europa.eu/events/2015/12/15/webinars-imi-2-calls-7-and-8
    AVÍS IMPORTANT
    Deadline for the 7th call is 17th March 2016.
    The 8th call for proposals is continuously open for a period of two years with the following cut-off dates for submission of proposals:
  • 16 March 2016,
  • 15 September 2016,
  • 16 March 2017,
  • 14 September 2017,
  • 15 March 2018.

    • Arxius

    Arxiu
    Provisions for participanting in IMI2
    8th call topic text
    7th call topic text
    Submission Manual